Richard S. Sutin

Biography

Richard Sutin handles capital market transactions and mergers and acquisitions for private and publicly traded corporations, provides ongoing corporate and securities law advice to issuers and financial intermediaries, regularly advises boards of directors and special board committees, and mediates shareholder disputes.

Mr. Sutin is Co-Chair of our Cleantech Team, a former member of our Executive Committee and a past member of the Advisory Committee to the Ontario Securities Commission.

Year of Call

• Ontario Bar 1977

Law School

• LL.B., Osgoode Hall Law School, 1975

EDUCATION

• B.A. (Hons.), York University, 1972

Selected Client Work

Mr. Sutin has acted recently for the following clients:

• Advised Bioniche Life Sciences and Bioniche Urology in connection with the US licence, development and supply agreement with Endo Pharmaceuticals for Bioniche's lead drug candidate Urocidin^TM, a mycobacterial cell wall-DNA complex which Bioniche Life Sciences developed and owns
• TSX Group, Second Cup, Chapters, Cinram, ComDev, Connor Clark, SIR Royalty Fund and Pet Valu on initial public offerings
• Cathay Forest Products, Neo Materials (formerly AMR Technologies), Bioniche Life Sciences, Toronto Hospital, Monarch Development Corp. and Hurricane Hydrocarbons in secondary financing assignments
• Connor Clark in the sale to Royal Bank
• The controlling shareholder of Canadian General Investments/Third Canadian General Investment Trust in successfully defending a hostile bid from AGF
• Peter Cundill & Associates in a strategic alliance with MacKenzie Financial Corporation
• The acquirors in the purchase of a strategic stake in Arbor Capital
• The controlling shareholder of Sodisco-Howden in the sale to Canwell Building Products
• The Special Committee of Rogers Wireless in both an unsuccessful and subsequent successful going-private transaction with Rogers Communications
• Special Committees of Centrefund, GSW Corp. and Sterling Centrecorp in sale transactions

Publications

• "Governance Strategies for Biotech Executives," Biotech Magazine, Winter 2002.
• "Board v. Hedge," Financial Post, May 25, 2006.
• "Corporate Directors and the New Insurgency," Private Capital Journal, Summer 2006.

Speaking Engagements

• "Insider Reporting and Trading, Selected Issues," The Canadian Institute Securities Law Superconference, 1991 and 1992.
• "Advertisement of Securities," Ontario Bar Association Seminar on Issues facing the Non-Publicly Traded Company, November 1990.
  

Media Highlights

• "Toronto Stock Exchanges Rule The Cleantech Roost," National Post, June 30, 2010.
• "The Future Of Clean Cars," BNN, May 25, 2009.
• "Clean Tech Fuels Growing Client Base," Canadian Lawyer, September 18, 2008.
• "A Mid-2008 Report On Developments In Canadian M&A And Investment Law And Practice," ACC Docket: Canadian Briefings, September 1, 2008.
• "Provinces Collide Over Green Targets," National Post, July 23, 2008.
• "Safety in Niches," National, May 28, 2008.
• "Canadian M&A in 2008: The After Party," Lexpert , May 26, 2008.
• "OSC Signals Environmental Liability Disclosures are Serious," Law Times, May 12, 2008.

Rankings and Recognitions

• Lexpert / American Lawyer Guide to the Leading 500 Lawyers in Canada - Most frequently recommended for Corporate Mid-Market 

Memberships and Activities

• Law Society of Upper Canada
• Canadian Bar Association
  • Past member, Standing Committee on Securities Laws
  • Past member, Special Committee to Consider New Ontario Loan and Trust Corporations Act
• Ontario Bar Association
  • Past member of executive, Business Law subsection

Directorships

• Connor Clark
• Connor Clark Private Trust
• Denninghouse
• Sodisco-Howden
• First Mercantile Currency Fund
• Caledon Trust Company
• Served on the boards or committees of several not-for-profit organizations